MRK - Merck & Co., Inc.

NYSE - NYSE Prezzo differito. Valuta in USD.

Merck & Co., Inc.

2000 Galloping Hill Road
Kenilworth, NJ 07033
United States
908 740 4000
http://www.merck.com

SettoreHealthcare
SettoreDrug Manufacturers—General
Impiegati a tempo pieno71.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Kenneth C. FrazierChairman, Pres & CEO6,64M28,28M1955
Mr. Robert M. DavisExec. VP of Global Services & CFO3,29M10,18M1967
Ms. Jennifer L. ZacharyExec. VP, Gen. Counsel & Corp. Sec.2,47MN/D1978
Dr. Roger M. PerlmutterExec. VP & Pres of Merck Research Laboratories3,55MN/D1952
Mr. Sanat ChattopadhyayExec. VP & Pres of Merck Manufacturing Division2,01M2,98M1960
Gli importi risalgono al giorno 31 dicembre 2019 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Merck & Co., Inc. provides healthcare solutions worldwide. It operates through Pharmaceutical and Animal Health segments. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products; and dog, cat, and horse vaccines. The company serves drug wholesalers and retailers, hospitals, government agencies, managed health care providers, physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; PeptiDream Inc.; Shanghai Junshi Biosciences Co., Ltd.; Targovax ASA; and Linnaeus Therapeutics, Inc. It also has strategic research collaboration and license agreement with Yumanity Therapeutics. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Governance aziendale

L'ISS Governance QualityScore di Merck & Co., Inc. al 7 dicembre 2019 è 2. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 7; diritti degli azionisti: 2; retribuzione: 2.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.
Usando Yahoo accetti che Yahoo e i suoi partners utilizzino cookies per fini di personalizzazione e altre finalità